S E Rivkin
- Hematology top 5%
- Oncology top 10%
- Neutropenia and Cancer Infections 2
- Cancer Treatment and Pharmacology 2
-
- Sarcoma Diagnosis and Treatment 3
- Lung Cancer Treatments and Mutations 2
-
- Acute Lymphoblastic Leukemia research 2
-
- Neuroendocrine Tumor Research Advances 3
-
- Lymphoma Diagnosis and Treatment 3
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- Tate ThigpenR BottomleyW. J. StuckeyRalph VanceRobert B. LivingstonTerence N. MooreZwi SteigerLyubica Dabich
- Journals
- Journal of Clinical Oncology (4 papers)Blood (2 papers)Annals of Internal Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
S E Rivkin
13 papers receiving 870 citations
Peers
Comparison fields: 5 of 53
- Hematology 241
- Oncology 414
- Pulmonary and Respiratory Medicine 453
- Public Health, Environmental and Occupational Health 209
- Genetics 75
Countries citing papers authored by S E Rivkin
This map shows the geographic impact of S E Rivkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S E Rivkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S E Rivkin more than expected).
Fields of papers citing papers by S E Rivkin
This network shows the impact of papers produced by S E Rivkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S E Rivkin. The network helps show where S E Rivkin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S E Rivkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 45 | |
| 2 | 1989 | 113 | |
| 3 | 1989 | 95 | |
| 4 | 1987 | 240 | |
| 5 | 1987 | 74 | |
| 6 | 1986 | 66 | |
| 7 | Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study. | 1984 | 2 |
| 8 | Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study. | 1982 | 2 |
| 9 | Phase II evaluation of bisantrene in patients with renal cell carcinoma. | 1982 | 10 |
| 10 | Vinblastine, bleomycin, and cis-dichlorodiammineplatinum(II) in disseminated testicular cancer: preliminary report of a Southwest Oncology Group Study. | 1980 | 7 |
| 11 | Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. | 1980 | 95 |
| 12 | 1978 | 186 | |
| 13 | Palliation in malignant pleural effusion. | 1975 | 7 |
About S E Rivkin
S E Rivkin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hematology, Pathology and Forensic Medicine and Reproductive Medicine, having authored 13 papers that have together received 942 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer therapeutics and mechanisms (2 papers), Acute Lymphoblastic Leukemia research (2 papers), Neutropenia and Cancer Infections (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Hematology (241 citations), Oncology (414 citations), Pulmonary and Respiratory Medicine (453 citations), Public Health, Environmental and Occupational Health (209 citations) and Genetics (75 citations). S E Rivkin has collaborated with scholars based in United States. Frequent co-authors include Tate Thigpen, R Bottomley, W. J. Stuckey, Ralph Vance, Robert B. Livingston, Terence N. Moore, Zwi Steiger, Lyubica Dabich, Daniel E. Lehane and Lance K. Heilbrun. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Internal Medicine, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.